Public Employees Retirement Association of Colorado Decreases Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Public Employees Retirement Association of Colorado reduced its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 0.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 244,866 shares of the medical device company’s stock after selling 369 shares during the period. Public Employees Retirement Association of Colorado owned about 0.12% of Cooper Companies worth $22,511,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Aquatic Capital Management LLC purchased a new stake in shares of Cooper Companies in the fourth quarter worth $2,904,000. Susquehanna Fundamental Investments LLC purchased a new stake in shares of Cooper Companies in the fourth quarter worth $10,322,000. Nebula Research & Development LLC increased its stake in shares of Cooper Companies by 182.1% in the fourth quarter. Nebula Research & Development LLC now owns 23,867 shares of the medical device company’s stock worth $2,194,000 after purchasing an additional 15,406 shares in the last quarter. Kovitz Investment Group Partners LLC purchased a new stake in shares of Cooper Companies in the fourth quarter worth $251,000. Finally, Syon Capital LLC increased its stake in shares of Cooper Companies by 9.7% in the fourth quarter. Syon Capital LLC now owns 2,845 shares of the medical device company’s stock worth $262,000 after purchasing an additional 251 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 2.0 %

Shares of NASDAQ:COO opened at $80.89 on Monday. The Cooper Companies, Inc. has a 52-week low of $69.81 and a 52-week high of $112.38. The stock has a market cap of $16.18 billion, a P/E ratio of 41.48, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The business’s 50 day moving average is $82.13 and its 200 day moving average is $92.59. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

COO has been the subject of a number of research reports. Robert W. Baird dropped their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a research report on Friday, March 7th. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Friday, March 7th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus dropped their target price on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Finally, Citigroup decreased their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and an average price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.